- Home
- SNTI vs LEDS Comparison
SNTI vs LEDS Comparison
Compare SNTI & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- LEDS
- Stock Information
- Founded
- SNTI 2016
- LEDS 2005
- Country
- SNTI United States
- LEDS Taiwan
- Employees
- SNTI N/A
- LEDS N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- LEDS Semiconductors
- Sector
- SNTI Health Care
- LEDS Technology
- Exchange
- SNTI Nasdaq
- LEDS Nasdaq
- Market Cap
- SNTI 10.4M
- LEDS 9.4M
- IPO Year
- SNTI N/A
- LEDS 2010
- Fundamental
- Price
- SNTI $4.41
- LEDS $1.38
- Analyst Decision
- SNTI Strong Buy
- LEDS
- Analyst Count
- SNTI 1
- LEDS 0
- Target Price
- SNTI $12.00
- LEDS N/A
- AVG Volume (30 Days)
- SNTI 7.0M
- LEDS 79.0K
- Earning Date
- SNTI 11-14-2024
- LEDS 01-10-2025
- Dividend Yield
- SNTI N/A
- LEDS N/A
- EPS Growth
- SNTI N/A
- LEDS N/A
- EPS
- SNTI N/A
- LEDS N/A
- Revenue
- SNTI N/A
- LEDS $5,183,000.00
- Revenue This Year
- SNTI $254.47
- LEDS N/A
- Revenue Next Year
- SNTI $169.66
- LEDS N/A
- P/E Ratio
- SNTI N/A
- LEDS N/A
- Revenue Growth
- SNTI N/A
- LEDS N/A
- 52 Week Low
- SNTI $1.52
- LEDS $0.92
- 52 Week High
- SNTI $16.94
- LEDS $2.29
- Technical
- Relative Strength Index (RSI)
- SNTI 52.77
- LEDS 50.13
- Support Level
- SNTI $4.62
- LEDS $1.21
- Resistance Level
- SNTI $5.96
- LEDS $1.70
- Average True Range (ATR)
- SNTI 1.63
- LEDS 0.12
- MACD
- SNTI -0.14
- LEDS 0.01
- Stochastic Oscillator
- SNTI 18.48
- LEDS 24.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.